Rinucumab (REGN 2176) is a monoclonal antibody designed to inhibit platelet-derived growth factor (PDGF), making it a valuable tool for research into neovascular age-related macular degeneration. This antibody specifically targets PDGF pathways, which are implicated in the pathological angiogenesis associated with this condition. Rinucumab (REGN 2176) is utilized primarily in studies aimed at understanding and potentially mitigating the progression of neovascular age-related macular degeneration.
Rinucumab (REGN 2176) is a monoclonal antibody designed to inhibit platelet-derived growth factor (PDGF), making it a valuable tool for research into neovascular age-related macular degeneration. This antibody specifically targets PDGF pathways, which are implicated in the pathological angiogenesis associated with this condition. Rinucumab (REGN 2176) is utilized primarily in studies aimed at understanding and potentially mitigating the progression of neovascular age-related macular degeneration.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
